Newstral
Article
South China Morning Post on 2020-04-15 11:41
Anti-malarial treatment hailed by Trump has no benefit for coronavirus patients, French researchers find
Related news
- Medical group endorses anti-malarial drug treatment for coronavirus patientsNew York Post
- Rumored coronavirus treatment creates shortage of vital anti-malarial drugsNew York Post
- Aspirin use has modest or no benefit for patients with hardened arteries, UF Health researchers findchipleybugle.com
- Ohio Pharmacy Board moves to prevent stockpiling of anti-malarial drugs being tested as COVID-19 treatmentcleveland.com
- FDA commissioner says anti-malarial drugs touted by Trump 'might have some benefit,' but more data neededFox News
- Ohio, federal authorities say they’re ready to investigate stockpiling of anti-malarial drugs Trump touted as potential coronavirus treatmentcleveland.com
- 'No benefit' in hydroxychloroquine virus treatment: studiesnation.co.ke
- Breakthrough treatment heals coronavirus patients in 72hrsvanguardngr.com
- Researchers identify new target in search for Alzheimer's treatmentbrisbanetimes.com.au
- French researchers to test nicotine patches on coronavirus patientsNew York Post
- NRegion’s cancer patients to benefit from innovative treatmentnewspostleader.co.uk
- Coast cancer patients to benefit from new treatment centrefrasercoastchronicle.com.au
- 1200 patients benefit from free eye medical treatment in Bauchitribuneonlineng.com
- Chinese nuclear weapons scientists build X-ray machine hailed as potential ‘holy grail’ for cancer treatmentSouth China Morning Post
- Transplant surgeon to hit the road to benefit patientspost-gazette.com
- NHS patients offered chance to visit France for treatmentexpressandstar.com
- BCoronavirus: Eight of nine UK patients receiving treatment dischargedbbc.co.uk
- Spain's regulator lets PharmaMar test treatment on COVID-19 patientsThe Jerusalem Post (JPost.com)